[Extension 'ConfigurationData' (3425) on page 'index/knowledgecenter/kc_her2_gastric_cancer/kc_her2_gastric_indication.htm'] Line 994: TypeError: objResult has no properties
Gastric Cancer Indication

Gastric Cancer Indication

Gastric cancer is the fourth most commonly diagnosed cancer. Recently, trastuzumab has shown to improve the survival of patients with advanced gastric cancer. Dako has also received approval from the U.S. FDA to expand the use of the HercepTest™ and HER2 pharmDx™ Kits to include patients with metastatic gastric or gastricesophageal junction adenocarcinoma*.

Leading pathologists endorse and use HercepTest™: See and hear why!


(*Lancet 2010; 376:687-07)

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.

Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement

Get in Touch with Dako in


Submit an Inquiry

How would you like us to follow up?

Your session expired

You have been logged out. Log in again to retrieve your Cart.